2009
DOI: 10.1177/1545968308331144
|View full text |Cite
|
Sign up to set email alerts
|

Minimal Detectable Change and Clinically Important Difference of the Wolf Motor Function Test in Stroke Patients

Abstract: The change score of an individual patient has to reach 4.36 and 0.37 on the WMFT time and WMFT FAS to indicate a real change. The mean change scores of a stroke group on the WMFT time and WMFT FAS should achieve 1.5 to 2 seconds and 0.2 to 0.4 points to be regarded as clinically important changes. Furthermore, the WMFT FAS may be more responsive than the WMFT time based on the results of proportions exceeding the threshold criteria.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
123
1
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 166 publications
(129 citation statements)
references
References 42 publications
3
123
1
2
Order By: Relevance
“…27 One SEM has been described as the preferred method for establishing the minimal detectable change (MDC) to identify important change beyond measurement error. 16,39 The SEM quantifies the measurement error in the units of the original measurement, which provides a clinically meaningful value to be interpreted by the clinician. 32 Ninety-five percent confidence intervals (CIs) were calculated for all reliability coefficients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…27 One SEM has been described as the preferred method for establishing the minimal detectable change (MDC) to identify important change beyond measurement error. 16,39 The SEM quantifies the measurement error in the units of the original measurement, which provides a clinically meaningful value to be interpreted by the clinician. 32 Ninety-five percent confidence intervals (CIs) were calculated for all reliability coefficients.…”
Section: Discussionmentioning
confidence: 99%
“…6 The within-patients change score was calculated as the mean change score (posttreatment minus baseline score) for each of the 4 physical performance measures, that corresponded to patients who were defined as having shown major improvement (that is, those with a GRCS greater than +5). 10,16 Using this approach, the MCII represents the mean change in scores of the major-improvement patients. The between-patients change score was calculated as the difference in the change score of the major-improvement and unimportant-change patients.…”
Section: Discussionmentioning
confidence: 99%
“…The participant demonstrated improvement on all motor outcomes and all but one nonmotor outcome at EOT and maintained or improved at EOT14 (Tables 2 and 3). Tables 2 and 3 also display minimal clinically important difference (MCID) and minimal detectable change (MDC; Fulk et al, 2008;Lang, Edwards, Birkenmeier, & Dromerick, 2008;Lin et al, 2009;Page, Fulk, & Boyne, 2012). The participant demonstrated a 20-point improvement on the FMA at EOT, achieving the MCID and MDC at EOT and EOT14.…”
Section: Resultsmentioning
confidence: 99%
“…In the past 5 years, a number of UL function tests have been examined for their psychometric and clinimetric properties in people with stroke, including the FuglMeyer Assessment (FMA) [6][7][8], Wolf Motor Function Test (WMFT) [6,[9][10][11], Box and Block Test (BBT) [7,[12][13][14], Nine-Hole Peg Test (NHPT) [12,[15][16][17], Action Research Arm Test (ARAT) [6][7][8]11,[16][17][18], and Stroke Impact Scale (SIS) [16,[19][20]. The comparisons of outcome measures of UL motor function have been investigated in patients with stroke [6][7]16,21].…”
Section: Introductionmentioning
confidence: 99%